Non Hodgkin Lymphoma Incidence and Mortality by Year, White Individuals, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 1,756 11.6 11.0-12.1 902 14.0 13.0-14.9 854 9.9 9.2-10.6 970 6.4 6.0-6.8 519 8.2 7.5-9.0 451 5.1 4.7-5.7
1977 1,787 11.7 11.2-12.3 909 13.9 13.0-14.9 878 10.1 9.4-10.8 972 6.4 6.0-6.8 475 7.4 6.7-8.1 497 5.6 5.1-6.1
1978 1,907 12.5 12.0-13.1 992 15.1 14.1-16.1 915 10.5 9.8-11.2 989 6.5 6.1-7.0 510 8.1 7.4-8.9 479 5.4 5.0-6.0
1979 1,863 12.4 11.8-13.0 913 14.4 13.4-15.4 950 10.9 10.2-11.6 994 6.6 6.2-7.0 521 8.3 7.6-9.1 473 5.3 4.9-5.9
1980 2,020 13.3 12.7-13.9 1,018 15.6 14.6-16.6 1,002 11.5 10.8-12.2 1,019 6.7 6.3-7.1 503 7.8 7.1-8.5 516 5.8 5.3-6.4
1981 2,032 13.4 12.8-14.0 988 15.4 14.5-16.5 1,044 11.9 11.1-12.6 1,014 6.6 6.2-7.1 505 8.0 7.3-8.8 509 5.6 5.1-6.1
1982 2,127 14.0 13.4-14.6 1,053 16.3 15.3-17.3 1,074 12.3 11.5-13.0 1,057 7.0 6.6-7.4 528 8.6 7.9-9.4 529 5.9 5.4-6.4
1983 2,230 14.7 14.0-15.3 1,118 17.4 16.4-18.5 1,112 12.5 11.7-13.3 1,119 7.4 7.0-7.8 573 9.1 8.3-9.9 546 6.1 5.6-6.7
1984 2,288 15.1 14.5-15.7 1,186 18.8 17.7-20.0 1,102 12.4 11.6-13.1 1,067 7.0 6.6-7.4 568 9.2 8.5-10.1 499 5.4 5.0-5.9
1985 2,453 16.2 15.5-16.9 1,302 20.3 19.2-21.5 1,151 12.9 12.2-13.7 1,181 7.7 7.3-8.2 625 10.0 9.2-10.8 556 6.1 5.6-6.6
1986 2,576 17.0 16.4-17.7 1,375 21.3 20.1-22.5 1,201 13.6 12.8-14.4 1,176 7.8 7.3-8.2 644 10.4 9.6-11.2 532 5.8 5.3-6.3
1987 2,555 16.9 16.3-17.6 1,366 21.3 20.2-22.5 1,189 13.4 12.6-14.2 1,192 7.8 7.4-8.3 598 9.5 8.7-10.3 594 6.5 6.0-7.0
1988 2,594 17.2 16.6-17.9 1,354 21.0 19.8-22.1 1,240 14.3 13.5-15.1 1,239 8.1 7.7-8.6 616 9.9 9.1-10.7 623 6.8 6.2-7.3
1989 2,693 18.0 17.3-18.7 1,472 22.7 21.6-24.0 1,221 14.1 13.3-14.9 1,243 8.2 7.7-8.6 677 10.8 10.0-11.7 566 6.2 5.7-6.7
1990 2,895 19.1 18.4-19.9 1,586 24.4 23.2-25.6 1,309 14.8 14.0-15.7 1,283 8.4 7.9-8.9 648 10.4 9.6-11.2 635 6.9 6.4-7.5
1991 3,002 19.9 19.2-20.6 1,629 25.4 24.2-26.7 1,373 15.7 14.9-16.6 1,280 8.4 7.9-8.8 674 10.8 10.0-11.7 606 6.5 6.0-7.1
1992 2,893 19.1 18.4-19.9 1,555 23.8 22.6-25.0 1,338 15.3 14.5-16.2 1,335 8.7 8.2-9.1 676 10.8 10.0-11.7 659 7.1 6.6-7.7
1993 2,981 19.7 19.0-20.5 1,633 24.8 23.6-26.1 1,348 15.4 14.6-16.3 1,243 8.0 7.6-8.5 631 10.0 9.2-10.8 612 6.6 6.0-7.1
1994 3,277 21.6 20.9-22.4 1,821 27.6 26.3-28.9 1,456 16.6 15.7-17.5 1,419 9.1 8.7-9.6 728 11.4 10.6-12.3 691 7.4 6.9-8.0
1995 3,220 21.2 20.5-21.9 1,721 26.1 24.9-27.4 1,499 17.1 16.3-18.0 1,409 9.1 8.6-9.5 731 11.6 10.8-12.5 678 7.3 6.7-7.8
1996 3,349 21.9 21.2-22.7 1,795 27.2 26.0-28.5 1,554 17.8 16.9-18.7 1,426 9.1 8.7-9.6 741 11.7 10.9-12.6 685 7.4 6.8-7.9
1997 3,354 21.8 21.1-22.6 1,736 26.1 24.9-27.4 1,618 18.3 17.4-19.2 1,478 9.4 8.9-9.9 747 11.5 10.7-12.4 731 7.8 7.3-8.4
1998 3,318 21.4 20.7-22.2 1,706 25.3 24.1-26.6 1,612 18.3 17.4-19.2 1,382 8.7 8.3-9.2 662 10.0 9.3-10.8 720 7.6 7.1-8.2
1999 3,368 21.6 20.8-22.3 1,699 25.1 24.0-26.4 1,669 18.8 17.9-19.7 1,312 8.2 7.7-8.6 637 9.8 9.0-10.6 675 7.1 6.6-7.7
2000 3,384 21.5 20.7-22.2 1,728 25.3 24.1-26.5 1,656 18.4 17.5-19.3 1,354 8.4 7.9-8.8 666 10.1 9.3-10.9 688 7.2 6.7-7.8
2001 3,353 21.1 20.4-21.8 1,731 25.3 24.1-26.5 1,622 17.9 17.1-18.9 1,261 7.7 7.3-8.2 688 10.2 9.5-11.0 573 5.8 5.3-6.3
2002 3,412 21.4 20.7-22.1 1,833 26.3 25.1-27.6 1,579 17.5 16.6-18.4 1,223 7.4 7.0-7.9 654 9.7 9.0-10.5 569 5.9 5.4-6.4
2003 3,609 22.5 21.7-23.2 1,847 26.3 25.1-27.6 1,762 19.3 18.4-20.3 1,134 6.8 6.4-7.2 572 8.5 7.8-9.2 562 5.6 5.1-6.1
2004 3,649 22.6 21.9-23.4 1,930 27.4 26.1-28.6 1,719 19.0 18.1-19.9 1,144 6.8 6.4-7.2 561 8.2 7.5-8.9 583 5.8 5.3-6.3
2005 3,743 23.1 22.4-23.9 1,963 27.6 26.4-28.9 1,780 19.5 18.6-20.5 1,111 6.6 6.2-7.0 582 8.4 7.8-9.2 529 5.3 4.8-5.8
2006 3,867 23.9 23.1-24.6 2,035 28.5 27.3-29.8 1,832 20.0 19.1-20.9 1,207 7.2 6.8-7.6 617 8.8 8.1-9.6 590 5.8 5.3-6.3
2007 3,840 23.5 22.7-24.2 2,034 28.2 27.0-29.5 1,806 19.8 18.9-20.7 1,088 6.4 6.0-6.8 596 8.4 7.7-9.1 492 4.9 4.5-5.4
2008 3,911 23.7 23.0-24.5 2,080 28.5 27.3-29.8 1,831 20.0 19.1-21.0 1,130 6.6 6.2-7.0 601 8.4 7.7-9.1 529 5.3 4.8-5.8
2009 3,999 24.0 23.3-24.8 2,115 28.7 27.5-30.0 1,884 20.4 19.4-21.3 1,080 6.2 5.8-6.6 599 8.2 7.6-8.9 481 4.7 4.3-5.2
2010 3,967 23.6 22.8-24.4 2,098 28.2 27.0-29.5 1,869 19.8 18.9-20.8 1,082 6.1 5.8-6.5 564 7.7 7.1-8.4 518 5.0 4.6-5.5
2011 3,944 23.4 22.6-24.1 2,116 28.1 26.9-29.3 1,828 19.6 18.7-20.5 1,080 6.1 5.7-6.5 565 7.6 6.9-8.2 515 5.0 4.6-5.5
2012 3,979 23.2 22.5-24.0 2,165 28.4 27.2-29.6 1,814 19.1 18.2-20.1 1,042 5.8 5.5-6.2 575 7.7 7.1-8.4 467 4.4 4.0-4.8
2013 4,087 23.6 22.9-24.4 2,223 28.8 27.6-30.1 1,864 19.4 18.5-20.3 981 5.4 5.1-5.8 530 7.0 6.4-7.6 451 4.2 3.8-4.7
2014 4,152 23.7 22.9-24.4 2,268 29.1 27.8-30.3 1,884 19.4 18.5-20.3 1,051 5.7 5.3-6.0 579 7.5 6.9-8.1 472 4.3 3.9-4.7
2015 4,129 23.4 22.7-24.2 2,263 28.4 27.2-29.6 1,866 19.4 18.5-20.3 990 5.4 5.1-5.8 562 7.2 6.6-7.9 428 4.0 3.6-4.4
2016 4,192 23.5 22.8-24.3 2,225 27.6 26.5-28.8 1,967 20.2 19.3-21.2 1,047 5.5 5.2-5.9 563 7.0 6.4-7.6 484 4.4 4.0-4.8
2017 4,174 23.2 22.5-23.9 2,269 27.9 26.7-29.1 1,905 19.4 18.5-20.4 1,070 5.6 5.3-6.0 593 7.3 6.7-8.0 477 4.3 3.9-4.7
2018 4,051 22.5 21.8-23.2 2,132 25.9 24.8-27.1 1,919 19.7 18.8-20.7 914 4.7 4.4-5.0 523 6.4 5.8-7.0 391 3.5 3.1-3.9
2019 4,196 22.8 22.1-23.5 2,288 27.3 26.2-28.5 1,908 19.2 18.3-20.1 939 4.8 4.5-5.1 519 6.2 5.7-6.8 420 3.7 3.3-4.1
2020 3,692 20.1 19.4-20.8 1,992 23.7 22.7-24.8 1,700 17.2 16.3-18.0 888 4.5 4.2-4.8 474 5.6 5.1-6.2 414 3.6 3.3-4.0

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.